InsiderFlow

Michael P Dube

NTLA

Michael P Dube serves as VP, Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$139.9K

Net Position

Net Seller

$139.9K

Companies Traded

1

NTLA

Active Period

Oct 2024 – Jan 2026

5 total trades

Most Recent

Sell NTLA

Jan 5, 2026 · $27.5K

Michael P Dube's Insider Trading at Intellia Therapeutics, Inc. (NTLA)

Buys

0 · $0.00

Sells

5 · $139.9K

Total Shares Bought

0

Total Shares Sold

10,747

NTLA Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Jan 5, 2026Sell2,989$9.21$27.5K0
Oct 1, 2025Sell1,871$17.38$32.5K0
Jul 2, 2025Sell2,503$9.95$24.9K0
Jan 7, 2025Sell1,372$12.18$16.7K45,640
Oct 4, 2024Sell2,012$19.01$38.2K47,012